Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis

J Neuroinflammation. 2017 Feb 7;14(1):31. doi: 10.1186/s12974-017-0801-1.

Abstract

Background: Central nervous system tuberculosis (CNS-TB) may be fatal even with treatment. Neutrophils are the key mediators of TB immunopathology, and raised CSF matrix metalloproteinase-9 (MMP-9) which correlates to neutrophil count in CNS-TB is associated with neurological deficit and death. The mechanisms by which neutrophils drive TB-associated CNS matrix destruction are not clearly defined.

Methods: Human brain biopsies with histologically proven CNS-TB were stained for neutrophils, neutrophil elastase, and MMP-9. Neutrophil MMP-9 secretion and gene expression were analyzed using Luminex and real-time PCR. Type IV collagen degradation was evaluated using confocal microscopy and quantitative fluorescent assays. Intracellular signaling pathways were investigated by immunoblotting and chemical inhibitors.

Results: MMP-9-expressing neutrophils were present in tuberculous granulomas in CNS-TB and neutrophil-derived MMP-9 secretion was upregulated by Mycobacterium tuberculosis (M.tb). Concurrent direct stimulation by M.tb and activation via monocyte-dependent networks had an additive effect on neutrophil MMP-9 secretion. Destruction of type IV collagen, a key component of the blood-brain barrier, was inhibited by neutralizing neutrophil MMP-9. Monocyte-neutrophil networks driving MMP-9 secretion in TB were regulated by MAP-kinase and Akt-PI3 kinase pathways and the transcription factor NF-kB. TNFα neutralization suppressed MMP-9 secretion to baseline while dexamethasone did not.

Conclusions: Multiple signaling paths regulate neutrophil-derived MMP-9 secretion, which is increased in CNS-TB. These paths may be better targets for host-directed therapies than steroids currently used in CNS-TB.

Keywords: Immunopathology; Matrix metalloproteinase; Neutrophils; Tuberculosis.

MeSH terms

  • Antibodies / pharmacology
  • Cells, Cultured
  • Chromones / pharmacology
  • Collagen Type IV / metabolism
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Expression Regulation, Bacterial / physiology*
  • Humans
  • Leukocytes / metabolism*
  • Male
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • Morpholines / pharmacology
  • Mycobacterium tuberculosis / physiology
  • NF-kappa B / genetics
  • NF-kappa B / immunology
  • NF-kappa B / metabolism
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Oncogene Protein v-akt / genetics
  • Oncogene Protein v-akt / metabolism
  • Peroxidase / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Tuberculosis, Central Nervous System / pathology*
  • Up-Regulation / drug effects
  • Up-Regulation / physiology

Substances

  • Antibodies
  • Chromones
  • Collagen Type IV
  • Enzyme Inhibitors
  • Morpholines
  • NF-kappa B
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Peroxidase
  • Oncogene Protein v-akt
  • Matrix Metalloproteinase 9